John C. Martin
2008 - Gilead Sciences
In 2008, John C. Martin earned a total compensation of $12.6M as Chairman and Chief Executive Officer at Gilead Sciences, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,651,650 |
|---|---|
| Option Awards | $6,859,160 |
| Salary | $1,146,261 |
| Stock Awards | $2,789,741 |
| Other | $107,131 |
| Total | $12,553,943 |
Martin received $6.9M in option awards, accounting for 55% of the total pay in 2008.
Martin also received $1.7M in non-equity incentive plan, $1.1M in salary, $2.8M in stock awards and $107.1K in other compensation.
Rankings
In 2008, John C. Martin's compensation ranked 179th out of 9,135 executives tracked by ExecPay. In other words, Martin earned more than 98.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 179 out of 9,135 | 98th |
Division Manufacturing | 54 out of 3,436 | 98th |
Major group Chemicals And Allied Products | 9 out of 815 | 99th |
Industry group Drugs | 7 out of 597 | 99th |
Industry Biological Products, Except Diagnostic Substances | 1 out of 118 | 99th |
Source: SEC filing on March 22, 2011.
Martin's colleagues
We found six more compensation records of executives who worked with John C. Martin at Gilead Sciences in 2008.
2008
John Milligan
Gilead Sciences
Chief Operating Officer
2008
Norbert Bischofberger
Gilead Sciences
Chief Scientific Officer
2008
Kevin Young
Gilead Sciences
Executive Vice President, Commercial Operations
2008
Robin Washington
Gilead Sciences
Chief Financial Officer
2008
Gregg Alton
Gilead Sciences
Executive Vice President, Corporate and Medical Affairs
2008
Caroline Dorsa
Gilead Sciences